Dr. Martin on the Frontline Treatment Landscape of MCL

Peter Martin, MD, chief, the Lymphoma Program, Meyer Cancer Center, associate professor of medicine, Weill Cornell Medicine, discusses the frontline treatment landscape of mantle cell lymphoma (MCL).

Unlike other lymphoma subtypes, there is not an established first-line standard of care in MCL, says Martin. Instead, there is a series of available options to select from.

Generally, younger, fitter patients are given intensive therapy, whereas older patients or those with multiple comorbidities are likely to receive less intensive chemoimmunotherapy regimens, explains Martin. 

The ultimate goal of therapy is to minimize the burden of the disease and maximize the patient’s quality of life, concludes Martin.